Roberto Caporali

InstitutionUniversity of Pavia
AddressPavia
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 31 Covid-19 publications, with a maximum of 6 publications in June 2020
    All Publications
    Bar chart showing 244 publications over 26 distinct years, with a maximum of 22 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schioppo T, Argolini LM, Sciascia S, Pregnolato F, Tamborini F, Miraglia P, Roccatello D, Sinico RA, Caporali R, Moroni G, Gerosa M. Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients. Rheumatology (Oxford). 2021 Aug 05. PMID: 34352079.
      Citations: 1     Fields:    
    2. Ingegnoli F, Buoli M, Posio C, Di Taranto R, Lo Muscio A, Cumbo E, Ostuzzi S, Caporali R. COVID-19 related poor mental health and sleep disorders in rheumatic patients: a citizen science project. BMC Psychiatry. 2021 08 03; 21(1):385. PMID: 34344329.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Cincinelli G, Di Taranto R, Orsini F, Rindone A, Murgo A, Caporali R. A case report of monoarthritis in a COVID-19 patient and literature review: Simple actions for complex times. Medicine (Baltimore). 2021 Jun 11; 100(23):e26089. PMID: 34114992.
      Citations: 2     Fields:    Translation:Humans
    4. Schälter F, Dürholz K, Bucci L, Burmester G, Caporali R, Figuereido C, Cobra JF, Manger B, Zaiss MM, Schett G. Does methotrexate influence COVID-19 infection? Case series and mechanistic data. Arthritis Res Ther. 2021 06 10; 23(1):166. PMID: 34112217.
      Citations: 2     Fields:    Translation:HumansAnimals
    5. Favalli EG, Maioli G, Biggioggero M, Caporali R. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Rev Clin Immunol. 2021 06; 17(6):561-571. PMID: 33787418.
      Citations: 3     Fields:    Translation:Humans
    6. Ingegnoli F, Cincinelli G, Luppino AF, Favalli EG, Orenti A, Boracchi P, Caporali R. Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy. Ann Rheum Dis. 2021 09; 80(9):1243-1245. PMID: 33849919.
      Citations: 1     Fields:    Translation:Humans
    7. Batticciotto A, Marotto D, Giorgi V, Balzarini P, Favalli EG, Balduzzi S, Fredi M, Bazzani C, Sartorelli S, Ravagnani V, Tamanini S, Castelnovo L, Lurati AM, Farah S, Bongiovanni S, Caporali R, Dagna L, Faggioli P, Franceschini F, Montecucco CM, Salaffi F, Galli M, Cappelli A, Sarzi-Puttini P. Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection. Clin Exp Rheumatol. 2021 May-Jun; 39(3):695. PMID: 33635224.
      Citations:    Fields:    Translation:HumansPHPublic Health
    8. Perricone C, Bartoloni E, Cafaro G, Caporali R, Gerli R. Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'. Ann Rheum Dis. 2021 Jan 28. PMID: 33509794.
      Citations:    Fields:    
    9. Cavagna L, Zanframundo G, Codullo V, Pisu MG, Caporali R, Montecucco C. Telemedicine in rheumatology: a reliable approach beyond the pandemic. Rheumatology (Oxford). 2021 01 05; 60(1):366-370. PMID: 32893293.
      Citations: 9     Fields:    Translation:Humans
    10. Favalli EG, Bugatti S, Klersy C, Biggioggero M, Rossi S, De Lucia O, Bobbio-Pallavicini F, Murgo A, Balduzzi S, Caporali R, Montecucco C. Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis. Arthritis Res Ther. 2020 12 30; 22(1):290. PMID: 33380344.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    11. Sarzi-Puttini P, Marotto D, Caporali R, Montecucco CM, Favalli EG, Franceschini F, Fredi M, Balduzzi S, Bazzani C, Bongiovanni S, Giorgi V, Batticciotto A, Cappelli A, Balzarini P, Dagna L, Sartorelli S, Ravagnani V, Tamanini S, Farah S, Faggioli P, Castelnovo L, Lurati AM, Galli M, Salaffi F. Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study. J Autoimmun. 2021 01; 116:102545. PMID: 32972804.
      Citations: 9     Fields:    Translation:Humans
    12. Favalli EG, Monti S, Ingegnoli F, Balduzzi S, Caporali R, Montecucco C. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data? Arthritis Rheumatol. 2020 10; 72(10):1600-1606. PMID: 32506699.
      Citations: 34     Fields:    Translation:Humans
    13. Favalli EG, Ingegnoli F, Biggioggero M, Caporali R. Is there really room for anti-rheumatic drugs in the treatment of COVID-19? Scand J Rheumatol. 2020 09; 49(5):412-413. PMID: 32720847.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    14. Scirè CA, Carrara G, Zanetti A, Landolfi G, Chighizola C, Alunno A, Andreoli L, Caporali R, Gerli R, Sebastiani GD, Valesini G, Sinigaglia L. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19). Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):748-753. PMID: 32723435.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    15. Ramirez GA, Gerosa M, Beretta L, Bellocchi C, Argolini LM, Moroni L, Della Torre E, Artusi C, Nicolosi S, Caporali R, Bozzolo EP, Dagna L. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients. Semin Arthritis Rheum. 2020 10; 50(5):1150-1157. PMID: 32927376.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    16. Favalli EG, De Lucia O, Biggioggero M, Del Papa N, Caporali R. Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients. Ann Rheum Dis. 2021 05; 80(5):e75. PMID: 32561608.
      Citations: 5     Fields:    Translation:Humans
    17. Schett G, Manger B, Simon D, Caporali R. COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. 2020 08; 16(8):465-470. PMID: 32561873.
      Citations: 36     Fields:    Translation:CellsPHPublic Health
    18. Favalli EG, Caporali R. GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm? Lancet Rheumatol. 2020 Aug; 2(8):e448-e449. PMID: 33521666.
      Citations: 2     
    19. Costi S, Caporali R, Cimaz R. Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy. Paediatr Drugs. 2020 06; 22(3):263-264. PMID: 32297225.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    20. Favalli EG, Agape E, Caporali R. Dr. Favalli, et al reply. J Rheumatol. 2020 10 01; 47(10):1592. PMID: 32482654.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    21. Minniti A, Maglione W, Pignataro F, Cappadona C, Caporali R, Del Papa N. Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity. Clin Rheumatol. 2020 Jul; 39(7):2063-2065. PMID: 32462423.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    22. Favalli EG, Gerosa M, Murgo A, Caporali R. Are patients with systemic lupus erythematosus at increased risk for COVID-19? Ann Rheum Dis. 2021 02; 80(2):e25. PMID: 32451344.
      Citations: 12     Fields:    Translation:HumansCells
    23. Del Papa N, Sambataro G, Minniti A, Pignataro F, Caporali R. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? Autoimmun Rev. 2020 07; 19(7):102558. PMID: 32380317.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    24. Vitali C, Minniti A, Caporali R, Del Papa N. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19. Thromb Res. 2020 08; 192:21-22. PMID: 32416365.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    25. Coletto LA, Favalli EG, Caporali R. Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days. Dermatol Ther. 2020 07; 33(4):e13415. PMID: 32291828.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    26. Caporali R, Favalli EG. Managing patients with rheumatic conditions during the covid-19 pandemic. BMJ. 2020 04 27; 369:m1633. PMID: 32340996.
      Citations: 2     Fields:    
    27. Favalli EG, Agape E, Caporali R. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis. J Rheumatol. 2020 08 01; 47(8):1296. PMID: 32335513.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    28. Licciardi F, Giani T, Baldini L, Favalli EG, Caporali R, Cimaz R. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatr Rheumatol Online J. 2020 Apr 22; 18(1):35. PMID: 32321540.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    29. Favalli EG, Ingegnoli F, Cimaz R, Caporali R. What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. 2021 02; 80(2):e18. PMID: 32321723.
      Citations: 38     Fields:    Translation:Humans
    30. Favalli EG, Biggioggero M, Maioli G, Caporali R. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020 09; 20(9):1012-1013. PMID: 32251638.
      Citations: 74     Fields:    Translation:HumansCellsPHPublic Health
    31. Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev. 2020 May; 19(5):102523. PMID: 32205186.
      Citations: 162     Fields:    Translation:HumansCellsPHPublic Health
    Caporali's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (250)
    Explore
    _
    Co-Authors (121)
    Explore
    _
    Similar People (60)
    Explore
    _